Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies

Documenti analoghi

• Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
  di: Dana J. Holger, et al.
  Pubblicazione: (2024)
• Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
  di: Daniela Gorski, et al.
  Pubblicazione: (2025)
• SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
  di: Erin F. Barreto, et al.
  Pubblicazione: (2026)
• Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
  di: Shawn Flanagan, et al.
  Pubblicazione: (2024)
• Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
  di: Aya M. AbdelMagid, et al.
  Pubblicazione: (2026)